BlackRock Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.02M Buy
76,434
+4,577
+6% +$73.9K ﹤0.01% 2123
2016
Q3
$1.33M Buy
71,857
+14,372
+25% +$253K ﹤0.01% 1876
2016
Q2
$704K Sell
57,485
-571
-1% -$4.3K ﹤0.01% 2130
2016
Q1
$391K Buy
58,056
+12,217
+27% +$78.2K ﹤0.01% 2336
2015
Q4
$423K Sell
45,839
-761
-2% -$7.08K ﹤0.01% 2262
2015
Q3
$838K Buy
46,600
+17,974
+63% +$413K ﹤0.01% 1986
2015
Q2
$851K Buy
28,626
+3,977
+16% +$99.9K ﹤0.01% 2038
2015
Q1
$543K Buy
24,649
+10,951
+80% +$278K ﹤0.01% 2161
2014
Q4
$376K Buy
13,698
+4,241
+45% +$103K ﹤0.01% 2330
2014
Q3
$184K Buy
9,457
+5,680
+150% +$104K ﹤0.01% 2477
2014
Q2
$64K Hold
3,777
﹤0.01% 2671
2014
Q1
$54K Hold
3,777
﹤0.01% 2634
2013
Q4
$44K Buy
+3,777
New +$43.3K ﹤0.01% 2568

Other funds holding EXAS

BlackRock Group's EXAS Position: Q4 2016 in Review

BlackRock Group increased its Exact Sciences (EXAS) stake by 6.4% in Q4 2016, buying an estimated $73.9K and bringing the position to 76,434 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2123.

BlackRock Group first reported a position in EXAS in Q4 2013 and has held it in 13 quarters since. The position peaked at $1.33M in Q3 2016. 222 funds tracked by Wall St. Rank hold EXAS as of Q4 2016.

  • BlackRock Group held 76,434 shares of Exact Sciences worth $1.02M as of Q4 2016.
  • BlackRock Group bought 4,577 Exact Sciences shares in Q4 2016, an estimated $73.9K.
  • Exact Sciences made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2123 holding.
  • BlackRock Group first reported a position in Exact Sciences in Q4 2013 and has held it in 13 quarters since.
  • BlackRock Group's Exact Sciences position peaked at $1.33M in Q3 2016.
  • 222 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.